San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, Tempo Therapeutics is raising $3,898,500.00 in new funding. Sources indicate as part of senior management President, Westbrook Weaver played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Tempo Therapeutics

Tempo develops materials that are immune stealth, minimally invasive, and precision engineered for regenerative medicine. We give power to regenerative medicine by controlling patient immunity to build synthetic tissue hybrids – from skin to bone to heart to brain.

To learn more about Tempo Therapeutics, visit http://tempothera.com/

Contact:
Westbrook Weaver, President
251-654-4070
https://www.linkedin.com/in/westbrook-weaver-b106ab17/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved